These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 19462446

  • 1. Overexpression of beta-catenin is responsible for the development of portal hypertension during liver cirrhosis.
    Hong JJ, Pan FY, Qian Y, Cheng LC, Zhang HX, Xue B, Li CJ.
    Anat Rec (Hoboken); 2009 Jun; 292(6):818-26. PubMed ID: 19462446
    [Abstract] [Full Text] [Related]

  • 2. [Adrenoceptors in the hepatic tissues in cirrhotic rats and cirrhotic patients with portal hypertension].
    Feng H, Leng X, Zhang Z.
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):175-7. PubMed ID: 9596953
    [Abstract] [Full Text] [Related]

  • 3. Increased Smad1 expression and transcriptional activity enhances trans-differentiation of hepatic stellate cells.
    Shen H, Fan J, Burczynski F, Minuk GY, Cattini P, Gong Y.
    J Cell Physiol; 2007 Sep; 212(3):764-70. PubMed ID: 17525996
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M, Genescà J, Raurell I, Rodríguez-Vilarrupla A, Mejías M, Otero T, Oria M, Esteban R, Guardia J, Bosch J, Martell M.
    J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Akt gene therapy for cirrhotic rats with portal hypertension].
    Huang FZ, Deng G, Liu XY, Luo CQ.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):31-7. PubMed ID: 18245901
    [Abstract] [Full Text] [Related]

  • 7. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
    Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C, Roskams T, Bioulac-Sage P, Zucman-Rossi J.
    J Hepatol; 2008 Jul; 49(1):61-71. PubMed ID: 18466996
    [Abstract] [Full Text] [Related]

  • 8. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.
    Matei V, Rodríguez-Vilarrupla A, Deulofeu R, García-Calderó H, Fernández M, Bosch J, Garcia-Pagán JC.
    J Hepatol; 2008 Aug; 49(2):192-7. PubMed ID: 18534709
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
    Wang CP, Han J, Ma XM, Dong K, Xiang Y, Su SH, Feng YY, Yang YP.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 14; 85(47):3337-41. PubMed ID: 16409839
    [Abstract] [Full Text] [Related]

  • 12. Expression of alpha1 adrenoceptor subtypes mRNA in hepatic tissues of cirrhotic patients with portal hypertension.
    Zhu J, Chen L, Leng X, Du R.
    Zhonghua Wai Ke Za Zhi; 2000 May 14; 38(5):325-8. PubMed ID: 11832047
    [Abstract] [Full Text] [Related]

  • 13. Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver.
    Kamath PS, Carpenter HA, Lloyd RV, McKusick MA, Steers JL, Nagorney DM, Miller VM.
    Liver Transpl; 2000 Sep 14; 6(5):596-602. PubMed ID: 10980059
    [Abstract] [Full Text] [Related]

  • 14. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.
    Laleman W, Vander Elst I, Zeegers M, Servaes R, Libbrecht L, Roskams T, Fevery J, Nevens F.
    Eur J Clin Invest; 2006 Apr 14; 36(4):242-9. PubMed ID: 16620286
    [Abstract] [Full Text] [Related]

  • 15. A rat model of liver cirrhosis and esophageal varices.
    Sakadamis AK, Ballas KD, Tzioufa-Asimakopoulou V, Alatsakis MB.
    Res Exp Med (Berl); 2001 Mar 14; 200(3):137-54. PubMed ID: 11426666
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Early propranolol administration does not prevent development of esophageal varices in cirrhotic rats.
    Alatsakis M, Ballas KD, Pavlidis TE, Psarras K, Rafailidis S, Tzioufa-Asimakopoulou V, Marakis GN, Sakantamis AK.
    Eur Surg Res; 2009 Mar 14; 42(1):11-6. PubMed ID: 18971580
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The role of hepatic sinusoid capillarization during the formation of portal hypertension in fibrotic rats induced by dimethylnitrosamine].
    Lu X, Liu P, Xu GF, Liu CH, Li FH, Liu C.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct 14; 11(10):595-8. PubMed ID: 14572335
    [Abstract] [Full Text] [Related]

  • 20. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis.
    Moreno-Merlo F, Wanless IR, Shimamatsu K, Sherman M, Greig P, Chiasson D.
    Hepatology; 1997 Sep 14; 26(3):554-60. PubMed ID: 9303482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.